202 related articles for article (PubMed ID: 27581614)
1. The journey of personalizing gastric cancer treatment.
Yan L
Chin J Cancer; 2016 Aug; 35(1):84. PubMed ID: 27581614
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer: current and evolving treatment landscape.
Sun W; Yan L
Chin J Cancer; 2016 Aug; 35(1):83. PubMed ID: 27581465
[TBL] [Abstract][Full Text] [Related]
4. From standard to new genome-based therapy of gastric cancer.
Lianos GD; Mangano A; Cho WC; Roukos DH
Expert Rev Gastroenterol Hepatol; 2015; 9(8):1023-6. PubMed ID: 26108988
[TBL] [Abstract][Full Text] [Related]
5. What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives.
Tirino G; Pompella L; Petrillo A; Laterza MM; Pappalardo A; Caterino M; Orditura M; Ciardiello F; Galizia G; De Vita F
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205505
[TBL] [Abstract][Full Text] [Related]
6. Comparison and applicability of molecular classifications for gastric cancer.
Serra O; Galán M; Ginesta MM; Calvo M; Sala N; Salazar R
Cancer Treat Rev; 2019 Jul; 77():29-34. PubMed ID: 31195213
[TBL] [Abstract][Full Text] [Related]
7. TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics.
Zhang W
Chin J Cancer; 2014 Oct; 33(10):469-70. PubMed ID: 25223913
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine.
Choi YY; Noh SH; Cheong JH
Yonsei Med J; 2015 Sep; 56(5):1177-85. PubMed ID: 26256958
[TBL] [Abstract][Full Text] [Related]
9. How Can Gastric Cancer Molecular Profiling Guide Future Therapies?
Corso S; Giordano S
Trends Mol Med; 2016 Jul; 22(7):534-544. PubMed ID: 27260398
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-induced drug resistance in gastric cancer.
Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
[TBL] [Abstract][Full Text] [Related]
11. Companion diagnostics for the targeted therapy of gastric cancer.
Yoo C; Park YS
World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
[TBL] [Abstract][Full Text] [Related]
12. Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
Choi YY; Cheong JH
Eur J Surg Oncol; 2017 May; 43(5):856-864. PubMed ID: 28330821
[TBL] [Abstract][Full Text] [Related]
13. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Singh SS; Yap WN; Arfuso F; Kar S; Wang C; Cai W; Dharmarajan AM; Sethi G; Kumar AP
World J Gastroenterol; 2015 Nov; 21(43):12261-73. PubMed ID: 26604635
[TBL] [Abstract][Full Text] [Related]
14. Advanced gastric cancer: Current treatment landscape and future perspectives.
Digklia A; Wagner AD
World J Gastroenterol; 2016 Feb; 22(8):2403-14. PubMed ID: 26937129
[TBL] [Abstract][Full Text] [Related]
15. Drug sensitivity testing platforms for gastric cancer diagnostics.
Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
[TBL] [Abstract][Full Text] [Related]
16. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
Wang S; Yuan L
Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
[TBL] [Abstract][Full Text] [Related]
17. Emerging molecular classifications and therapeutic implications for gastric cancer.
Chen T; Xu XY; Zhou PH
Chin J Cancer; 2016 May; 35():49. PubMed ID: 27233623
[TBL] [Abstract][Full Text] [Related]
18. TRP channels in gastric cancer: New hopes and clinical perspectives.
Sterea AM; Egom EE; El Hiani Y
Cell Calcium; 2019 Sep; 82():102053. PubMed ID: 31279156
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy in gastric cancer: personalizing cancer treatment based on patient genome.
Lim SM; Lim JY; Cho JY
World J Gastroenterol; 2014 Feb; 20(8):2042-50. PubMed ID: 24587678
[TBL] [Abstract][Full Text] [Related]
20. Future perspectives for the development of chemotherapy for advanced gastric cancer: Japanese and global status.
Higuchi K; Tanabe S; Azuma M; Sasaki T; Ishido K; Koizumi W
Pathobiology; 2011; 78(6):334-42. PubMed ID: 22104205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]